Carrier Screening Market Size to Reach $6.5 Billion by 2031: Says AMR

Portland, OR, Feb. 01, 2023 (GLOBE NEWSWIRE) — A new business intelligence report released by Allied Market Research, the global Carrier Screening Market size was estimated at $1.8 billion in 2021 and is expected to hit $6.5 billion by 2031, registering a CAGR of 13.8% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/11636

Report coverage & details:

Covid-19 scenario-

• Disrupted healthcare services including genetic counseling that resulted in a reduction in the patient influx to genetic counselors and workforce shortages to perform the essential functions required of newborn screening (NBS) programs had a negative impact on the global carrier screening market.
• However, as the global situation has recovered, the market has now got back on track, due to increased demand for carrier screening.

The global carrier screening market is analyzed across type, technology, end-user, and region. The report takes in an exhaustive analysis of the segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/11636

By type, the expanded carrier screening segment held the largest share in 2021, garnering around three-fourth of the global carrier screening market revenue, and is projected to maintain its dominance by 2031. The expanded carrier screening segment would also showcase the fastest CAGR of 14.7% during the forecast period.

By technology, the DNA sequencing segment contributed to nearly half of the global carrier screening market share in 2021 and is projected to rule the roost by 2031. The polymerase chain reaction segment, on the other hand, would display the fastest CAGR of 14.9% throughout the forecast period.

By end-user, the hospitals and clinics segment accounted for the highest share in 2021, generating nearly half of the global carrier screening market revenue. The reference laboratories segment would also portray the fastest CAGR of 14.8% during the forecast period.

By region, North America held the major share in 2021, garnering nearly half of the global carrier screening market revenue. Asia-Pacific would showcase the fastest CAGR of 14.9% from 2022 to 2031.

The key market players analyzed in the global carrier screening market report include Diasorin S.p.A (Luminex Corporation), Eurofins Scientific, Fulgent Genetics Inc., Illumina Inc., Invitae Corporation, Myriad Genetics Inc., Natera Inc., Opko Health Inc., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc. These market players have embraced several strategies including product launch, product approval, and acquisition to highlight their prowess in the industry. The report is helpful in formulating the business performance and developments by the top players.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Healthcare IT Market by Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services), and End User (Healthcare Providers and Healthcare Payers): Global Opportunity Analysis and Industry Forecast, 2021-2030

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecule (Genetic Biomarkers, Protein Biomarkers, and Glyco-biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Others), and Application (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Cosmetic Implants Market by Product (Dental Implants, Breast Implants, Facial Implants, Other Implants), by Biomaterial (Polymers, Metals, Ceramics, Biomaterials): Global Opportunity Analysis and Industry Forecast, 2020-2030

Endoscopy Devices Market by Product Type (Endoscope, Mechanical Endoscopic Equipment, Visualization & Documentation Systems, Accessories, and Others), Hygiene (Single-use, Reprocessing, and Sterilization), Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Gynecology Endoscopy, ENT Endoscopy, and Others), and End User (Hospitals, Ambulatory Surgery Centers & Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2030

Neuromodulation Market by Technology (Internal Neuromodulation, External Neuromodulation), by Application (Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications), by Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), : Global Opportunity Analysis and Industry Forecast, 2020-2030

Surgical Sutures Market by Type (Automated Suturing Devices and Sutures), Material (Monofilament and Multifilament), Application (Cardiovascular Surgeries, General Surgeries, Gynecological Surgeries, Orthopedic Surgeries, and Ophthalmic Surgeries): Global Opportunity Analysis and Industry Forecast, 2020-2027

Remote Patient Monitoring Market by Condition (Congestive Heart Failure (CHF), Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Blood Pressure, Mental Health, Others), by Component (Devices, Software): Global Opportunity Analysis and Industry Forecast, 2021-2031

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2020- 2030

Fetal Monitoring Market by Product {Ultrasound (2D, 3D & 4D, and Doppler Imaging), Intrauterine Pressure Catheter (IUPC), Telemetry Solutions, Electronic Fetal Monitoring (EFM) (External & Internal), Fetal Electrodes, Fetal Doppler, Accessories & Consumables, and Other Products}, Method (Invasive and Non-Invasive), Portability (Portable and Non-Portable), Application (Intrapartum Fetal Monitoring and Antepartum Fetal Monitoring): Global Opportunity Analysis and Industry Forecast, 2020-2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.